Implementing 5-dose Measles-Rubella Vaccine Vials in Zambia Research Findings

From January 2017 through July 2018, the DPCP conducted implementation research using quantitative and qualitative methods in Central and Luapula provinces in Zambia. The country was selected to carry out this work because of Ministry of Health (MOH) interest and commitment to engaging in the implementation research; a functional supply chain; minimal regulatory barriers to introducing a new presentation; and support from in-country and regional partners. The DPCP introduced 5-dose vials of measles-rubella (MR) vaccine to a select group of health facilities (HFs) in May 2017 to assess the effects on the immunization system of reducing the number of DPC from the 10-dose vials in use.